In genome-wide expression analysis of bladder cancer cells treated with demethylating agents 5-aza-2’-cytidine and zebularine (168–170), FGF18 expression was downregulated in eight bladder cancer cell lines. The gene discussed is FGF18; the disease is urinary bladder cancer.